The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGattaca Regulatory News (GATC)

Share Price Information for Gattaca (GATC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 93.00
Bid: 92.00
Ask: 94.00
Change: 0.00 (0.00%)
Spread: 2.00 (2.174%)
Open: 93.00
High: 93.00
Low: 93.00
Prev. Close: 93.00
GATC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Continuation of Share Buy-back

13 Nov 2023 07:00

RNS Number : 1398T
Gattaca PLC
13 November 2023
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU NO. 596/2014) AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 ("MAR").

 

 

13 November 2023

 

Gattaca plc

 

("Gattaca", the "Company" or "the Group")

 

Continuation of Share Buy-back

 

On 21 August 2023 Gattaca plc ("Gattaca", the "Company" or the "Group"), the specialist staffing solutions business, announced its intention to return up to £0.5 million to shareholders via a series of share repurchases (the "Share Buy-back"). Over the weeks following this announcement, Gattaca returned approximately £390k to shareholders prior to going into a close period on 23 September 2023 pending release of the Group's FY23 results, at which point the Share Buy-back was halted.

 

The Company today confirms the relaunch of the Share Buy-back, to repurchase ordinary shares in the capital of the Company ("Ordinary Shares") up to an aggregate value of approximately £109k, being the remaining balance of the £0.5 million intended to be returned to shareholders[, as announced on 21 August 2023.]

 

The Share Buy-back will be operated in accordance with the terms of the Company's general authority to repurchase Ordinary Shares granted by shareholders at its annual general meeting (the "AGM"), held on 6 December 2022.

 

In accordance with the authority granted at the AGM; a) the aggregate number of Ordinary Shares to be repurchased will not exceed 2,448,101 (being the remaining balance of the shareholder authority when taking into account the various share repurchases by the Company since the AGM); b) the minimum price which may be paid for each Ordinary Share will be £0.01; and c) the maximum price (excluding expenses) which may be paid for each Ordinary Share will be 105% of the average middle market quotations for an Ordinary Share as derived from the AIM appendix to the Daily Official List of the London Stock Exchange plc for the five business days immediately preceding the day on which the Ordinary Share is contracted to be purchased.

 

The Company intends to limit (but retains discretion over) the number of Ordinary Shares repurchased daily, such that the aggregate price paid (being the total number of Ordinary Shares repurchased multiplied by the average price paid for each Ordinary Share, including expenses) on any given trading day is expected to not exceed £50,000.

 

Shareholders should be aware that a purchase of Ordinary Shares by the Company on any trading day may represent a significant proportion of the daily trading volume in the Ordinary Shares and could exceed 25 per cent. of the average daily trading volume of the preceding 20 business days. Should that be the case, the Company could exceed the pricing and/or volume restrictions as established by the Commission Delegated Regulation 2016/1052/EU (as in force in the UK and as amended by the FCA's Technical Standards (Market Abuse Regulation) (EU Exit) Instrument 2019) (the "Regulation") and therefore the Share Buy-back may not fall within the safe harbour provisions of the Regulation. 

 

As part of the Share Buy-back, Liberum Capital Limited, the Company's broker, has been appointed to purchase the Ordinary Shares as principal. Ordinary Shares purchased pursuant to the Share Buy-back will be cancelled.

 

For further information please contact:

Gattaca plc

+44 (0) 1489 898989

Matthew Wragg, Chief Executive Officer

Oliver Whittaker, Chief Financial Officer

 

Liberum Capital Limited (Nomad and Broker)

+44 (0) 20 3100 2000

Lauren Kettle

Richard Lindley

IFC Advisory

+44 (0) 203 934 6630

Tim Metcalfe

Graham Herring

Florence Chandler

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSFFDFMSEDSEFF
Date   Source Headline
16th Apr 20247:00 amRNSInterim Results
2nd Apr 20247:00 amRNSBlock listing six monthly return
15th Feb 20247:00 amRNSTrading Update
25th Jan 20247:00 amRNSExercise of Options
6th Dec 20235:07 pmRNSDirector/PDMR Shareholding
6th Dec 20234:51 pmRNSResults of Annual General Meeting
28th Nov 20237:00 amRNSTransaction in Own Shares
27th Nov 20237:00 amRNSTransaction in Own Shares
24th Nov 20237:00 amRNSTransaction in Own Shares
22nd Nov 20237:00 amRNSTransaction in Own Shares
21st Nov 20237:00 amRNSTransaction in Own Shares
20th Nov 20237:00 amRNSTransaction in Own Shares
17th Nov 20237:00 amRNSTransaction in Own Shares
15th Nov 20237:00 amRNSTransaction in Own Shares
14th Nov 20237:00 amRNSTransaction in Own Shares
13th Nov 20237:00 amRNSContinuation of Share Buy-back
13th Nov 20237:00 amRNSAvailability of Report & Accounts and AGM Notice
25th Oct 20237:00 amRNSDirector/PDMR Share Purchase
25th Oct 20237:00 amRNSEBT Share Purchase Programme
24th Oct 20237:01 amRNSBoard Changes
24th Oct 20237:00 amRNSFinal results for the year ended 31 July 2023
17th Oct 20237:00 amRNSInvestor webinar 24 October 2023
2nd Oct 20239:00 amRNSBlock Listing Interim Review
25th Sep 20237:05 amRNSTransaction in Own Shares
25th Sep 20237:00 amRNSExercise of Options and Director/PDMR Shareholding
21st Sep 20237:00 amRNSTransaction in Own Shares
20th Sep 20237:00 amRNSTransaction in Own Shares
19th Sep 20237:00 amRNSTransaction in Own Shares
15th Sep 20237:00 amRNSTransaction in Own Shares
14th Sep 20237:00 amRNSTransaction in Own Shares
13th Sep 20237:00 amRNSTransaction in Own Shares
12th Sep 20237:00 amRNSTransaction in Own Shares
11th Sep 20237:00 amRNSTransaction in Own Shares
8th Sep 20237:00 amRNSTransaction in Own Shares
7th Sep 20237:00 amRNSTransaction in Own Shares
6th Sep 20237:00 amRNSTransaction in Own Shares
5th Sep 20237:00 amRNSTransaction in Own Shares
4th Sep 20237:00 amRNSTransaction in Own Shares
1st Sep 20237:00 amRNSTransaction in Own Shares
31st Aug 20237:00 amRNSTransaction in Own Shares
30th Aug 20237:00 amRNSTransaction in Own Shares
24th Aug 20237:00 amRNSTransaction in Own Shares
22nd Aug 20237:00 amRNSTransaction in Own Shares
21st Aug 20232:05 pmRNSHolding(s) in Company
21st Aug 20237:00 amRNSLaunch of Share Buy-back
16th Aug 20237:00 amRNSTrading Update
12th May 20237:00 amRNSHolding(s) in Company
10th May 20237:00 amRNSTransaction in Own Shares
9th May 20237:00 amRNSTransaction in Own Shares
5th May 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.